Aptevo Therapeutics Raises $3 Million Through Warrant Exercise
Aptevo Therapeutics Inc. has secured $3.0 million in gross proceeds from the exercise of existing warrants. This capital infusion represents a significant financial development for the biotechnology company, providing additional funds for its operations and strategic initiatives.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.